05.29.14
Neptune Technologies & Bioressources Inc., Acasti Pharma Inc. and NeuroBioPharm Inc. have jointly appointed Andre Godin as interim president and chief executive officer of Neptune, Acasti and NeuroBio with immediate effect.
Mr. Godin is currently chief financial officer of Neptune. Since the recent resignation of the corporation’s former president and CEO, Mr. Godin has also been overseeing the management of the business with the support of a management and operations committee.
“Andre has been with Neptune since 2003 and has played an active leadership role in all aspects of the organization,” said Dr. Ronald Denis, chairman of the corporation. "He is a chartered professional accountant and also has more than 20 years of industry experience, including as former president of a dietary supplement company and as a corporate controller for a pharmaceutical company in over-the-counter (OTC) products. The corporation is in an important stage of its business development and Andre is well placed to oversee its strategic initiatives. We welcome him in his new functions."
Mr. Godin is currently chief financial officer of Neptune. Since the recent resignation of the corporation’s former president and CEO, Mr. Godin has also been overseeing the management of the business with the support of a management and operations committee.
“Andre has been with Neptune since 2003 and has played an active leadership role in all aspects of the organization,” said Dr. Ronald Denis, chairman of the corporation. "He is a chartered professional accountant and also has more than 20 years of industry experience, including as former president of a dietary supplement company and as a corporate controller for a pharmaceutical company in over-the-counter (OTC) products. The corporation is in an important stage of its business development and Andre is well placed to oversee its strategic initiatives. We welcome him in his new functions."
